Université de Bretagne Occidentale (U.B.O.);Inserm;Centre Hospitalier Régional et Universitaire de Brest
发明人:
申请号：
EP14290232.9
公开号：
EP2982982B1
申请日:
2014.08.06
申请国别(地区):
EP
年份:
2017
代理人:
摘要：
The invention relates to the use of the fraction of the STIM1 protein localized to the plasma membrane of the cells in a method for screening candidate molecules for treating chronic lymphatic leukaemia and/or systemic lupus erythematosus. The invention also relates to a substance interacting with the fraction of the STIM1 protein localized to the plasma membrane of the cells for use as a medicinal product in the treatment of chronic lymphatic leukaemia and/or systemic lupus erythematosus, as well as to a pharmaceutical composition comprising at least one substance according to the invention.
